The fight against COVID19
23.82k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The fight against COVID19 | +1.09% | - | - | - |
| ^GSPC | -0.21% | +5.47% | +27.37% | +5595.81% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 154.28 | +1.61 | +1.05% | 4:00 pm GMT-4 | 6.92M | 7.47M | 371.30B |
| ABBV | AbbVie Inc. | 164.35 | +0.56 | +0.34% | 4:00 pm GMT-4 | 4.29M | 5.62M | 290.22B |
| PFE | Pfizer Inc. | 28.92 | +0.10 | +0.35% | 4:01 pm GMT-4 | 34.30M | 42.74M | 163.88B |
| SNY | Sanofi | 48.82 | -0.19 | -0.39% | 4:00 pm GMT-4 | 1.96M | 2.01M | 122.39B |
| REGN | Regeneron Pharmaceuticals, Inc. | 967.98 | -10.23 | -1.05% | 4:00 pm GMT-4 | 386.50k | 456.51k | 106.66B |
| GSK | GSK plc | 44.88 | -0.44 | -0.98% | 4:00 pm GMT-4 | 3.51M | 3.17M | 94.54B |
| GILD | Gilead Sciences, Inc. | 67.86 | +0.85 | +1.27% | 4:00 pm GMT-4 | 4.75M | 7.02M | 84.54B |
| MRNA | Moderna, Inc. | 132.68 | +3.62 | +2.80% | 4:00 pm GMT-4 | 2.93M | 3.84M | 50.85B |
| TAK | Takeda Pharmaceutical Company Limited | 13.31 | -0.08 | -0.60% | 4:00 pm GMT-4 | 1.19M | 1.66M | 42.07B |
| BNTX | BioNTech SE | 92.98 | +0.78 | +0.85% | 4:00 pm GMT-4 | 389.05k | 593.01k | 22.41B |
| NVAX | Novavax, Inc. | 14.4 | +1.50 | +11.63% | 4:00 pm GMT-4 | 24.79M | 12.76M | 2.12B |
| VIR | Vir Biotechnology, Inc. | 9.93 | -0.09 | -0.90% | 4:00 pm GMT-4 | 395.76k | 993.94k | 1.35B |
| INO | Inovio Pharmaceuticals, Inc. | 12.79 | -0.28 | -2.14% | 4:00 pm GMT-4 | 365.01k | 444.19k | 331.40M |
Evening StandardFTSE 100 Live 17 May: Land Securities results, GSK nets £1.25bn in final Haleon stake sale
GSK and Land Securities are in the FTSE 100 spotlight after the drugs giant sold its final Haleon shares and the property firm posted results. Land Securities revealed a smaller full-year loss of £341 million amid “robust” rental growth across its estate. The drugs giant initially held a 12.94% stake after the demerger of the consumer health business completed in July 2022.
BloombergGSK to Sell Remaining $1.6 Billion Stake in Haleon
(Bloomberg) -- GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the consumer health company.Most Read from BloombergUS Inflation Data Was Accidentally Released 30 Minutes EarlyWith a BlackRock CEO, $9 Trillion Vanguard Braces for TurbulencePutin and Xi Vow to Step Up Fight to Counter US ‘Containment’Jamie Dimon Sees ‘Lot of Inflationary Forces in Front of Us’Dow Average Touches 40,000 Before Pulling Back: Markets Wra
- Investing.com
Asia FX weakens as dollar recovers amid waning rate cut cheer
Investing.com-- Most Asian currencies retreated on Friday as the dollar recovered a measure of recent losses after a string of Federal Reserve officials warned that bets on interest rate cuts may be premature.
